| 01/22 | GlaxoSmithKline-Owned ViiV Healthcare Says US FDA Approved its HIV Drug Caben.. | MT |
| 01/22 | GLAXOSMITHKLINE : ViiV Healthcare announces FDA approval of Cabenuva (cabotegrav.. | AQ |
| 01/22 | MARKET CHATTER : Pfizer, BioNTech Reportedly Agree to Supply Vaccine for WHO-Bac.. | MT |
| 01/22 | BIONDVAX PHARMACEUTICALS : Announces Appointment of Amir Reichman as New CEO | AQ |
| 01/22 | GLAXOSMITHKLINE : GSK - ViiV Healthcare announces FDA approval of Cabenuva, the .. | AQ |
| 01/22 | IMMUTEP : Says Partner Glaxo Has Discontinued Phase II Study of Ulcerative Colit.. | MT |
| 01/21 | GSK Unit ViiV Healthcare's HIV-1 Infection Gets US FDA Approval | MT |
| 01/21 | GlaxoSmithKline Subsidiary ViiV Healthcare's Regimen for HIV-1 Gets FDA Appro.. | MT |
| 01/21 | GLAXOSMITHKLINE : Viiv Healthcare Announces FDA Approval Of Cabenuva For HIV Tre.. | RE |
| 01/21 | Pfizer-BioNTech agree to supply WHO co-led COVID-19 vaccine scheme -sources | RE |
| 01/21 | BIONDVAX PHARMACEUTICALS : Names Amir Reichman as CEO | MT |
| 01/20 | GLAXOSMITHKLINE : Goldman Sachs maintains a Buy rating | MD |
| 01/20 | Merck KGaA, GSK suffer lung cancer drug setback | RE |
| 01/20 | MERCK : stops lung cancer trial testing drug hopeful bintrafusp alfa | RE |
| 01/20 | GLAXOSMITHKLINE : UBS gives a Neutral rating | MD |
| 01/20 | GLAXOSMITHKLINE : Credit Suisse Downgrades GSK To Underperform From Neutral, Low.. | MT |
| 01/20 | GLAXOSMITHKLINE : Downgraded to Sell by Credit Suisse | MD |
| 01/20 | GLAXOSMITHKLINE : Jefferies remains its Buy rating | MD |
| 01/19 | GLAXOSMITHKLINE : ViiV Healthcare and Chelsea and Westminster Hospital continue .. | AQ |
| 01/19 | Novartis, GSK Kick Off Exploration of African Genetic Diversity to Improve Tr.. | MT |
| 01/19 | Novartis, GlaxoSmithKline Launch Research on Genetic Diversity in Africa | MT |
| 01/19 | GSK, Novartis Announce Collaboration To Support Scientific Research Into Gene.. | RE |
| 01/19 | GLAXOSMITHKLINE : GSK and Novartis announce collaboration to support scientific .. | PU |
| 01/18 | HIKMA PHARMACEUTICALS : provides update on generic Advair Diskus launch | AQ |
| 01/18 | GLAXOSMITHKLINE : GSK's Dostarlimab Shows Nearly 39% Objective Response Rate in .. | MT |
| 01/17 | HIKMA PHARMACEUTICALS : Pauses Asthma Drug Launch to Amend US FDA Application | MT |
| 01/15 | GLAXOSMITHKLINE : Deutsche Bank Starts GlaxoSmithKline at Hold | MT |
| 01/15 | European ADRs Move Sharply Lower in Friday Trading | MT |
| 01/15 | GLAXOSMITHKLINE : Deutsche Bank gives a Neutral rating | MD |
| 01/15 | GLAXOSMITHKLINE : JP Morgan gives a Neutral rating | MD |
| 01/14 | GLAXOSMITHKLINE : Conference transcript PDF - 125.9KB | PU |
| 01/13 | GLAXOSMITHKLINE : Unit Gets European Marketing Authorization for HIV Medication .. | MT |
| 01/13 | GLAXOSMITHKLINE : ViiV Healthcare Wins EU Marketing Approval For HIV-1 Drug | MT |
| 01/13 | GLAXOSMITHKLINE : ViiV Healthcare receives EU Marketing Authorisation for the fi.. | PU |
| 01/12 | MODERNA : Operation Warp Speed chief adviser resigns, Biden's transition officia.. | RE |
| 01/12 | GLAXOSMITHKLINE : JP Morgan Conference presentation | PU |
| 01/12 | Vectura Expects 2020 Revenue, Adjusted EBITDA To Beat Estimates On US Approva.. | MT |
| 01/12 | GLAXOSMITHKLINE : GSK, Vir Biotechnology to Evaluate VIR-7832 Antibody for Treat.. | MT |
| 01/12 | VIR BIOTECHNOLOGY : Second Vir-GSK Monoclonal Antibody to Be Assessed as Potenti.. | MT |
| 01/12 | GSK, Vir to test antibody for COVID-19 treatment | RE |
| 01/11 | GLAXOSMITHKLINE : Eligo Bioscience Enters Into A Research And Option Agreement W.. | RE |
| 01/11 | GLAXOSMITHKLINE : Signs Acne Deal With Eligo Bioscience | MT |
| 01/08 | Correction to Drugmakers Raise Prices Article of Jan. 1 | DJ |
| 01/08 | GLAXOSMITHKLINE : Australian Regulator Accepts GlaxoSmithKline's Extension Appli.. | MT |
| 01/08 | GLAXOSMITHKLINE : GSK, MMV filing for Kozenis (tafenoquine) in paediatric popula.. | PU |
| 01/08 | EU countries cannot negotiate separate vaccine deals - EU chief | RE |
| 01/08 | EU has new deal with Pfizer for 300 mln more COVID vaccine doses | RE |
| 01/07 | Sanofi says could help produce competitors' COVID-19 shots | RE |
| 01/07 | CureVac strikes COVID-19 vaccine alliance with Bayer | RE |
| 01/06 | CureVac strikes COVID-19 vaccine alliance deal with Bayer -Bild | RE |
| 01/06 | CureVac strikes COVID-19 vaccine alliance deal with Bayer -Bild | RE |
| 01/05 | GLAXOSMITHKLINE : Drugmakers kick off 2021 with 500 U.S. price hikes | RE |
| 01/04 | GSK, Philips Team Up to Offer Child Vaccination Information to Parents | MT |
| 01/04 | GLAXOSMITHKLINE : Gets a Buy rating from Goldman Sachs | MD |
| 01/04 | GLAXOSMITHKLINE : JP Morgan remains Neutral | MD |
| 01/04 | GSK, Sanofi and Pfizer Mull Price Increases For Over 300 Drugs In US | MT |
| 01/03 | Explainer-Where are we in the COVID-19 vaccine race? | RE |
| 2020 | EXCLUSIVE : Drugmakers to hike prices for 2021 as pandemic, political pressure p.. | RE |
| 2020 | Drugmakers to hike prices for 2021 as pandemic, political pressure put revenu.. | RE |
| 2020 | UK blue chips hit 9-month high on Brexit trade deal cheer | RE |
| 2020 | European ADRs Move Higher in Tuesday Trading | MT |
| 2020 | VECTURA : GlaxoSmithKline Decides Against Rehearing Appeal In Ellipta Trial | MT |
| 2020 | UK blue chips hit 9-month high on Brexit trade deal cheer | RE |
| 2020 | Drugmakers Agree to Steep Price Cuts to be Covered by China's National Insura.. | MT |
| 2020 | Pfizer to complete supply of COVID-19 vaccines to EU by September | RE |
| 2020 | AstraZeneca, GSK Slash Drug Prices By 51% For China Inclusion | MT |
| 2020 | Businesses Brace for Disruption Despite Post-Brexit Trade Deal -- Update | DJ |
| 2020 | Businesses Brace for Disruption Despite Post-Brexit Trade Deal | DJ |
| 2020 | Logistics firms reap "vaccine economy" benefits as EU gears up for roll-out | RE |
| 2020 | Production and delivery challenges set up turbulent Year of the Vaccine | RE |
| 2020 | SOSEI : GlaxoSmithKline Enter Global Collaboration and License Agreement for Gas.. | MT |
| 2020 | Danaher Corp. Names New Chief Scientific Officer | DJ |
| 2020 | GLAXOSMITHKLINE : Morgan Stanley ESG Conference presentation PDF - 366.3KB | PU |
| 2020 | LIGAND PHARMACEUTICALS INCORPORATED : and GSK Sign License Agreement to Target N.. | MT |
| 2020 | GlaxoSmithKline Unit Secures European Marketing Approval for Long-Acting Inje.. | MT |
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
